BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6851263)

  • 1. Red cell survival and red cell enzymes in patients on continuous peritoneal dialysis (CAPD).
    Hefti JE; Blumberg A; Marti HR
    Clin Nephrol; 1983 May; 19(5):232-5. PubMed ID: 6851263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O; Boner G; Rosenfeld JB
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deformability and enzymes activities of red blood cells in hemodialysed and peritoneal dialysed patients with chronic renal disease.
    Nowak-Piszczek E; Wyrwicz G; Dabrowski Z; Smoleński O; Spodaryk K
    Clin Hemorheol Microcirc; 2003; 28(4):251-7. PubMed ID: 12897415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell calcium level in chronic renal failure: effect of continuous ambulatory peritoneal dialysis.
    Gafter U; Malachi T; Barak H; Levi J
    J Lab Clin Med; 1990 Sep; 116(3):386-92. PubMed ID: 2144869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoiesis in the anaemia of chronic renal failure: the response to CAPD.
    Coles GA; Cavill I
    Nephrol Dial Transplant; 1986; 1(3):170-4. PubMed ID: 3110671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell metabolism in renal failure--the effect of dialysis.
    Chu P; Cadley M; Bellingham AJ
    Clin Lab Haematol; 1985; 7(1):1-5. PubMed ID: 4006401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hexokinase activity of erythrocytes in cancer patients].
    Sensini A; Braussi M; Spadoni M; Giacchi R
    Quad Sclavo Diagn; 1981 Dec; 17(4):431-7. PubMed ID: 7347823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of erythrocytes phosphatidylserine exposure in anemia in peritoneal dialysis patients.
    Bi SH; Cheng LT; Wang T
    Ren Fail; 2006; 28(7):573-6. PubMed ID: 17050240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exogenous reduced glutathione on the survival of red blood cells in hemodialyzed patients.
    Usberti M; Lima G; Arisi M; Bufano G; D'Avanzo L; Gazzotti RM
    J Nephrol; 1997; 10(5):261-5. PubMed ID: 9364318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the effect of alteration in the acidity of the dialysis solution on the survival time and the metabolism of the erythrocytes in patients with terminal renal insufficiency treated with long-term dialysis].
    Leuenberger R; Brunner F; Kummer H; Benninger JL; Hodler J
    Schweiz Med Wochenschr; 1972 Jan; 102(1):18-24. PubMed ID: 5010797
    [No Abstract]   [Full Text] [Related]  

  • 14. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis.
    Tang SC; Lam B; Ku PP; Leung WS; Chu CM; Ho YW; Ip MS; Lai KN
    J Am Soc Nephrol; 2006 Sep; 17(9):2607-16. PubMed ID: 16885414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erythrocyte enzymes in chronic kidney failure].
    Khlebarova M; Dishlianova B; Belovezhdov N; Robeva R; Savova R
    Vutr Boles; 1985; 24(1):120-7. PubMed ID: 4024601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
    Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
    J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrimidine 5'-nucleotidase and oxidative damage in red blood cells transfused to beta-thalassemic children.
    David O; Sacchetti L; Vota MG; Comino L; Perugini L; Pescarmona GP
    Haematologica; 1990; 75(4):313-8. PubMed ID: 2276676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.